FDA NDC Directory · JSON-LD · Markdown

Ozempic

NDC 0169-4181 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namesemaglutide
Labeler / ManufacturerNovo Nordisk
Marketing categoryNew Drug Application (innovator) · App NDA209637
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsSEMAGLUTIDE (.68 mg/mL)
Marketing started20221007
Package count2

External sources

Source: openFDA. Public-domain (CC0).